On-Demand CME Videos
FC24: Real-World Approaches to Actinic Keratosis Management: An Online Activity
About
FC24: Real-World Approaches to Actinic Keratosis Management: An Online Activity
This activity is supported by educational grants from Almirall and SUN Pharmaceutical Industries Ltd.
Availability
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
December 4, 2024
December 14, 2025
Learning Objectives
At the completion of this activity, participants should be better able to:
Define the various therapies available for the management of actinic keratosis
Describe expert recommended approaches for integrating combination AK therapies into practice
Identify approaches for delivering optimal patient-tailored AK therapeutic care
Intended Audience
Faculty
Brian Berman, MD, PhD
Professor Emeritus of Dermatology and Dermatologic Surgery
University of Miami, Miller School of Medicine
Miami, FL
Darrell Rigel, MS, MD
Clinical Professor of Dermatology
New York University
Grossman School of Medicine
New York, NY
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Grant/Research Support: Almirall, Sirnaomics, Mediwound, Minolab, Pulse
Consultant: Almirall, Aiviva, Novartis, Sensus, Verrica, Lemonex
Speakers’ Bureau or Honoraria: BPGBio (FKA Berg), BMS, Novan, Sirnaomics, Minolab, Pfizer, Verrica, Almirall, Sensus, Lemonex
Advisory Board: Castle Biosciences, Almirall
Grant/Research Support: Castle Biosciences
Consultant: Castle Biosciences
Speakers’ Bureau Honoraria: Beiersdorf, Castle Biosciences, Almirall, DermTech
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.